Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients
- 1 May 1992
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 41 (5) , 1374-1382
- https://doi.org/10.1038/ki.1992.202
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Deferoxamine Test and Bone Disease in Dialysis Patients With Mild Aluminum AccumulationAmerican Journal of Kidney Diseases, 1989
- Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.Clinical Chemistry, 1987
- Osteomalacia and Aplastic Bone Disease in Aluminum-Related Osteodystrophy*Journal of Clinical Endocrinology & Metabolism, 1987
- Bone histologic response to deferoxamine in aluminum–related bone diseaseKidney International, 1987
- The interaction of parathyroid hormone and aluminum in renal osteodystrophyKidney International, 1987
- Diagnostic Decision: Probability Theory in the Use of Diagnostic TestsAnnals of Internal Medicine, 1986
- Use of the Deferoxamine Infusion Test in the Diagnosis of Aluminum-Related OsteodystrophyAnnals of Internal Medicine, 1984
- The Use of Deferoxamine in the Management of Aluminum Accumulation in Bone in Patients with Renal FailureNew England Journal of Medicine, 1984